Detectability of Hypometabolic Regions in Mild Alzheimer Disease: Function of Time after the Injection of 2-[Fluorine 18]-Fluoro-2-Deoxy-d-Glucose

References

1. ↵
   Kumar A, Braun A, Schapiro M, Grady C, Carson R, Herscovitch P. Cerebral glucose metabolic retes after 30 and 45 minute acquisitions: A comparative study. J Nucl Med 1992;33:2103–2105

   Abstract/FREE Full Text
2. ↵
   Ishii K, Sasaki M, Kitagaki H, et al. Reduction of cerebellar glucose metabolism in advanced Alzheimer’s disease. J Nucl Med 1997;38:925–928

   Abstract/FREE Full Text
3. ↵
   Iida H, Miura S, Kanno I, et al. Design of evaluation of Headtome IV: a whole body positron emission tomograph. IEEE Trans Nucl Sci 1989;37:1006–1010

   CrossRef
4. ↵
   Ishii K, Willoch F, Minoshima S, et al. Statistical brain mapping of ¹⁸F-FDG PET in Alzheimer’s disease: validation of anatomic standardization for atrophied brains. J Nucl Med 2001;42:548–557

   Abstract/FREE Full Text
5. ↵
   Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 1995;36:1238–1248

   Abstract/FREE Full Text
6. ↵
   Friston KJ, Holmes AP, Worsely KJ, Poline JB, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Map 1995;2:189–210

   CrossRef
7. ↵
   Schmidt K, Lucignani G, Moresco RM, et al. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [¹⁸F]fluorodeoxyglucose method. J Cereb Blood Flow Metab 1992;12:823–834

   PubMed
8. ↵
   Ishii K, Sakamoto S, Hosaka K, Mori T, Sasaki M. Variation in FDG uptake in different regions in normal human brain as a function of the time (30 and 60 minutes) after injection of FDG. Ann Nucl Med 2002;16:299–301

   PubMed
9. ↵
   Fukuyama H, Kameyama M, Harada K, et al. Glucose metabolism and rate constants in Alzheimer’s disease examined with dynamic positron emission tomography scan. Acta Neurol Scand 1989;80:307–313

   PubMed
10. ↵
    Minoshima S, Foster NL, Kuhl DE. Posterior cingulate cortex in Alzheimer’s disease. Lancet 1994;344:895

    PubMedWeb of Science
11. ↵
    Turkington TG, Coleman RE, Schubert SF, et al. An evaluation of post-injection transmission measurement in PET. IEEE Trans Nucl Sci 1993;41:1538–1544